Skip to content

Medical-device intelligence

QJR: Reagents, 2019-Novel Coronavirus Nucleic Acid

FDA product code QJR: Reagents, 2019-Novel Coronavirus Nucleic Acid. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QJR
FDA device name
Reagents, 2019-Novel Coronavirus Nucleic Acid
Device class
N
Regulation number
Not provided
Medical specialty
Unknown
Review panel
MI

FDA definition

Nucleic acid-based in vitro diagnostic devices for the detection of 2019-novel coronavirus (2019-nCoV) and/or diagnosis of 2019-nCoV infection in human clinical specimens.
Explore unknown records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

0 clearance records and 40 recall records in the covered releases, across 16 source company names and 1 product codes. Dated history runs from Jul 20, 2020 to Apr 28, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
QJR · Reagents, 2019-Novel Coronavirus Nucleic Acid040

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

40 matching records
Device / recordCompany in FDA recordSourceSource date
OPTI SARS-CoV-2 RT-PCR Test, REF Numbers: a) 99-57003 b) 99-57004Z-2310-2021 · QJROPTI Medical Systems, IncRecallAug 17, 2021FDA record creation date
NeuMoDx Cartridge, For In Vitro Diagnostic Use on the NeuMoDx 288 and NeuMoDx 96 Molecular Systems, Model Number 100100Z-1978-2021 · QJRNeuMoDx Molecular IncRecallJun 29, 2021FDA record creation date
Lyra SARS-CoV-2 Assay (M120) in vitro diagnostic test reagentZ-1928-2021 · QJRQuidel CorporationRecallJun 26, 2021FDA classification date
Revogene SARS-CoV-2 Catalog Number: 410700 IVD for real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on …Z-1540-2021 · QJRMeridian Bioscience IncRecallMay 7, 2021FDA record creation date
Revogene RNA Software Upgrade Kit Revogene RNA Software Upgrade USBs Catalog Number: 610240 IVD used to install the Revogene System Software ver…Z-1541-2021 · QJRMeridian Bioscience IncRecallMay 7, 2021FDA record creation date
cobas SARS-CoV-2 & Influenza A/B assay cobas Liat- Reagents, 2019-Novel Coronavirus Nucleic Acid for use on the cobas Liat System, Catalog Numbe…Z-1413-2021 · QJRRoche Molecular Systems, Inc.RecallApr 13, 2021FDA record creation date
cobas Liat Analyzer: respiratory virus panel nucleic acid assay system Catalog Number: 07341920190Z-1414-2021 · QJRRoche Molecular Systems, Inc.RecallApr 13, 2021FDA record creation date
BioGX SARS-CoV-2 Reagents for BD MAX System-IVD PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasophary…Z-1416-2021 · QJRBecton Dickinson & Co.RecallApr 13, 2021FDA record creation date
BioGX SARS-CoV-2 Reagents for BD MAX System Catalog number (REF) 444213. In vitro diagnostic. SARS-CoV-2 Reagents is a real-time RT-PCR test…Z-0954-2021 · QJRBecton Dickinson & Co.RecallFeb 5, 2021FDA record creation date
Nucleic acid-based in vitro diagnostic devices for the detection of 2019-novel coronavirus (2019-nCoV) and/or diagnosis of 2019-nCoV infection in…Z-0940-2021 · QJRBiomeme, Inc.RecallFeb 1, 2021FDA record creation date
visby medical COVID-19 Test kit *** An in vitro diagnostic for the qualitative detection of SARS-CoV-2 - Product Usage: The Visby Medical COVID-1…Z-0847-2021 · QJRVISBY MEDICAL INCRecallJan 12, 2021FDA record creation date
The Biomeme SARS-CoV-2 Real-Time RT-PCR Test is a molecular in vitro diagnostic test that is based on widely used nucleic acid amplification tech…Z-0513-2021 · QJRBiomeme, Inc.RecallDec 1, 2020FDA record creation date
The TaqPath RT-PCR COVID-19 Kit with Applied Biosystem's COVID-19 Interpretive Software v1.2 for 7500 RTPCR instruments, includes the assays and …Z-2978-2020 · QJRLife Technologies CorporationRecallSep 17, 2020FDA record creation date
The TaqPath RT-PCR COVID-19 Kit with Applied Biosystem's COVID-19 Interpretive Software v2.0 or v2.2 (used with the QuantStudio Real-Time PCR pla…Z-2979-2020 · QJRLife Technologies CorporationRecallSep 17, 2020FDA record creation date
BD MAX SARS-CoV-2 Reagents, Cat. No. 445003 (UDI 00382904450038) and 445003-01 (UDI (01)603829044500301) - Product Usage: intended for the qualit…Z-2754-2020 · QJRBecton Dickinson & Co.RecallAug 4, 2020FDA record creation date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗